These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 27847174

  • 1. Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections.
    Adhikari RP, Thompson CD, Aman MJ, Lee JC.
    Vaccine; 2016 Dec 07; 34(50):6402-6407. PubMed ID: 27847174
    [Abstract] [Full Text] [Related]

  • 2. Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia.
    Adhikari RP, Karauzum H, Sarwar J, Abaandou L, Mahmoudieh M, Boroun AR, Vu H, Nguyen T, Devi VS, Shulenin S, Warfield KL, Aman MJ.
    PLoS One; 2012 Dec 07; 7(6):e38567. PubMed ID: 22701668
    [Abstract] [Full Text] [Related]

  • 3. Role of antibodies in protection elicited by active vaccination with genetically inactivated alpha hemolysin in a mouse model of staphylococcus aureus skin and soft tissue infections.
    Mocca CP, Brady RA, Burns DL.
    Clin Vaccine Immunol; 2014 May 07; 21(5):622-7. PubMed ID: 24574539
    [Abstract] [Full Text] [Related]

  • 4. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X, Wang X, Thompson CD, Park S, Park WB, Lee JC.
    mBio; 2016 Feb 02; 7(1):e02232-15. PubMed ID: 26838725
    [Abstract] [Full Text] [Related]

  • 5. Vaccine display on artificial bacterial spores enhances protective efficacy against Staphylococcus aureus infection.
    Karauzum H, Updegrove TB, Kong M, Wu IL, Datta SK, Ramamurthi KS.
    FEMS Microbiol Lett; 2018 Sep 01; 365(18):. PubMed ID: 30084923
    [Abstract] [Full Text] [Related]

  • 6. Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate.
    Delfani S, Mohabati Mobarez A, Imani Fooladi AA, Amani J, Emaneini M.
    Med Microbiol Immunol; 2016 Feb 01; 205(1):47-55. PubMed ID: 26155981
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.
    Brady RA, Mocca CP, Prabhakara R, Plaut RD, Shirtliff ME, Merkel TJ, Burns DL.
    PLoS One; 2013 Feb 01; 8(4):e63040. PubMed ID: 23658662
    [Abstract] [Full Text] [Related]

  • 8. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein.
    Uppalapati SR, Kingston JJ, Murali HS, Batra HV.
    Vaccine; 2014 May 23; 32(25):3075-81. PubMed ID: 24699467
    [Abstract] [Full Text] [Related]

  • 9. Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant.
    Camussone CM, Pujato N, Renna MS, Veaute CM, Morein B, Marcipar IS, Calvinho LF.
    Vet Immunol Immunopathol; 2014 Dec 15; 162(3-4):96-107. PubMed ID: 25454469
    [Abstract] [Full Text] [Related]

  • 10. Recombinant PBP2a as a vaccine candidate against methicillin-resistant Staphylococcus aureus: Immunogenicity and protectivity.
    Haghighat S, Siadat SD, Rezayat Sorkhabadi SM, Akhavan Sepahi A, Sadat SM, Yazdi MH, Mahdavi M.
    Microb Pathog; 2017 Jul 15; 108():32-39. PubMed ID: 28457901
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Auto-Assembling Detoxified Staphylococcus aureus Alpha-Hemolysin Mimicking the Wild-Type Cytolytic Toxin.
    Fiaschi L, Di Palo B, Scarselli M, Pozzi C, Tomaszewski K, Galletti B, Nardi-Dei V, Arcidiacono L, Mishra RP, Mori E, Pallaoro M, Falugi F, Torre A, Fontana MR, Soriani M, Bubeck Wardenburg J, Grandi G, Rappuoli R, Ferlenghi I, Bagnoli F.
    Clin Vaccine Immunol; 2016 Jun 15; 23(6):442-50. PubMed ID: 27030589
    [Abstract] [Full Text] [Related]

  • 13. In vivo mapping of a protective linear neutralizing epitope at the N-terminus of alpha hemolysin from Staphylococcus aureus.
    Oscherwitz J, Muñoz-Planillo R, Yu F, Núñez G, Cease KB.
    Mol Immunol; 2014 Jul 15; 60(1):62-71. PubMed ID: 24769493
    [Abstract] [Full Text] [Related]

  • 14. Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model.
    Zhang BZ, Hua YH, Yu B, Lau CC, Cai JP, Zheng SY, Yam WC, Kao RY, Sze KH, Zheng BJ, Yuen KY, Huang JD.
    Infect Immun; 2015 Jan 15; 83(1):339-45. PubMed ID: 25368117
    [Abstract] [Full Text] [Related]

  • 15. Targeting surface protein SasX by active and passive vaccination to reduce Staphylococcus aureus colonization and infection.
    Liu Q, Du X, Hong X, Li T, Zheng B, He L, Wang Y, Otto M, Li M.
    Infect Immun; 2015 May 15; 83(5):2168-74. PubMed ID: 25776748
    [Abstract] [Full Text] [Related]

  • 16. Protective immunization against Staphylococcus aureus infection in a novel experimental wound model in mice.
    Schennings T, Farnebo F, Szekely L, Flock JI.
    APMIS; 2012 Oct 15; 120(10):786-93. PubMed ID: 22958286
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of a novel chimeric B cell epitope-based vaccine against mastitis induced by either Streptococcus agalactiae or Staphylococcus aureus in mice.
    Xu H, Hu C, Gong R, Chen Y, Ren N, Xiao G, Xie Q, Zhang M, Liu Q, Guo A, Chen H.
    Clin Vaccine Immunol; 2011 Jun 15; 18(6):893-900. PubMed ID: 21508165
    [Abstract] [Full Text] [Related]

  • 20. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
    Hu DL, Narita K, Hyodo M, Hayakawa Y, Nakane A, Karaolis DK.
    Vaccine; 2009 Jul 30; 27(35):4867-73. PubMed ID: 19406185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.